Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amphastar Pharmaceuticals - 10 Year Stock Split History | AMPH

Stock split history for Amphastar Pharmaceuticals since 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
Amphastar Pharmaceuticals Annual Stock Splits
Amphastar Pharmaceuticals Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.963B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.440B 5.21
Dr Reddy's Laboratories (RDY) India $12.040B 19.04
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.408B 0.00
Bausch Health Cos (BHC) Canada $3.088B 2.41
Supernus Pharmaceuticals (SUPN) United States $1.626B 0.00
Taysha Gene Therapies (TSHA) United States $0.460B 0.00
Generation Bio (GBIO) United States $0.187B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00